Infusion Margin From 7% to 20% Without Adding a Single Chair

Operator Case Note — Capacity and Ancillaries

Infusion Margin From 7% to 20% Without Adding a Single Chair

Hospital-affiliated ambulatory infusion service, 14 chairs, mixed commercial and Medicare payer mix

7% → 20%

Contribution margin

same chair count, same footprint

+22%

Chair utilization

against pre-project baseline

<2%

Drug waste rate

down from a materially higher run rate

The Situation

Infusion was the second-largest revenue line in the service and among the least profitable. The instinct in the room was to add chairs and hire nurses, on the theory that more volume would fix the margin. The numbers said the opposite: every incremental chair would have amplified the losses already embedded in the workflow.

Chair utilization looked acceptable in aggregate but collapsed under inspection. Appointments were scheduled in uniform blocks regardless of infusion duration, which meant a 90-minute therapy and a five-hour therapy occupied the same slot. Mornings were congested, mid-afternoons were dead, and nursing overtime accrued in the evenings finishing long infusions that had started too late.

Prior authorization was handled reactively. Authorizations were often chased on the day of service, producing same-day cancellations, wasted prepared drug, and rescheduled patients who displaced other bookings.

Drug acquisition was not managed as a margin lever at all. Purchasing followed habit rather than contract terms, vial sizing was not matched to dosing patterns, and waste was accepted as a cost of doing business.

What the Numbers Showed

Every engagement starts with measurement. These were the findings that changed the priority order.

Uniform scheduling blocks against non-uniform therapies

Slot length ignored infusion duration, which guaranteed both idle chairs and end-of-day overtime in the same week.

Authorization work happened after scheduling, not before

Same-day authorization failures drove cancellations, drug waste, and a rebooking cycle that consumed capacity twice.

Drug spend was treated as pass-through, not managed

Vial sizing, dose rounding practice, and purchasing against contract terms were never reviewed together, so waste and acquisition cost both ran high.

Nursing ratios were set by headcount, not by acuity timeline

Staffing matched the number of chairs rather than the shape of the day, producing simultaneous idle time and overtime.

What We Changed

Rebuilt the schedule around therapy duration

Therapies were grouped into duration tiers and the template was redesigned so long infusions started early and short infusions filled the afternoon tail. The change required no capital and no new staff.

Moved prior authorization upstream with a hard rule

No patient was placed on the schedule without an authorization on file or a documented exception approved by a named person. Same-day authorization scrambles went from routine to rare.

Managed drug acquisition as an operational discipline

Vial sizing was matched to actual dosing distributions, purchasing was aligned to contract terms, and waste was tracked and posted weekly rather than absorbed silently.

Matched nursing coverage to the redesigned day

Coverage was built against the acuity timeline instead of the chair count, which removed most evening overtime while improving the mid-day throughput.

Put a weekly scorecard on the wall

Chair utilization, waste rate, same-day cancellations, and overtime hours were posted where the team could see them. The metrics stopped being a monthly surprise and became a daily habit.

The Outcome

Contribution margin moved from roughly 7% to roughly 20% with the same fourteen chairs and the same physical footprint. None of the gain came from volume growth; it came from removing waste that had been priced into the operation.

Chair utilization improved 22% against the baseline, and evening nursing overtime dropped sharply because long therapies no longer started at four in the afternoon.

Because the improvements were structural — a template, an authorization rule, a purchasing standard, a visible scorecard — they held after the project team stepped back.

The lesson

When a service line has strong revenue and weak margin, adding capacity multiplies the problem. Fix the workflow first, then decide whether you need more chairs. Most practices discover they do not.

These are operator case notes from our founder's prior executive and operating roles in ambulatory healthcare, described without identifying details. They are shared as evidence of method, not as Edison Breakwater client engagement results.